These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 7842186

  • 1. Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids.
    Rivington RN, Boulet LP, Côté J, Kreisman H, Small DI, Alexander M, Day A, Harsanyi Z, Darke AC.
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):325-32. PubMed ID: 7842186
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
    Britton MG, Earnshaw JS, Palmer JB.
    Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
    [Abstract] [Full Text] [Related]

  • 4. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U, Viktrup L, Davidsen O, Viskum K.
    Ugeskr Laeger; 1992 Nov 16; 154(47):3325-8. PubMed ID: 1361083
    [Abstract] [Full Text] [Related]

  • 5. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW, van der Mark TW, Koëter GH, Postma DS.
    Am J Respir Crit Care Med; 1996 Jan 16; 153(1):70-5. PubMed ID: 8542165
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhaled formoterol during one year in asthma: a comparison with salbutamol.
    Arvidsson P, Larsson S, Löfdahl CG, Melander B, Svedmyr N, Wåhlander L.
    Eur Respir J; 1991 Nov 16; 4(10):1168-73. PubMed ID: 1687129
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma.
    Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ.
    N Engl J Med; 1997 Nov 13; 337(20):1412-8. PubMed ID: 9358138
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C.
    Curr Med Res Opin; 2004 Sep 13; 20(9):1403-18. PubMed ID: 15383189
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
    Crompton GK, Ayres JG, Basran G, Schiraldi G, Brusasco V, Eivindson A, Jamieson AH, Olsson H.
    Am J Respir Crit Care Med; 1999 Mar 13; 159(3):824-8. PubMed ID: 10051257
    [Abstract] [Full Text] [Related]

  • 14. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K, Noonan M, Silkoff PE, Uryniak T.
    Clin Ther; 2007 Jun 13; 29(6):1013-26. PubMed ID: 17692718
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
    Lee YS, Lin HC, Huang CD, Lee KY, Liu CY, Yu CT, Wang CH, Kuo HP.
    Chang Gung Med J; 2011 Jun 13; 34(4):382-94. PubMed ID: 21880193
    [Abstract] [Full Text] [Related]

  • 16. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group.
    van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF.
    Am Rev Respir Dis; 1992 Sep 13; 146(3):547-54. PubMed ID: 1355640
    [Abstract] [Full Text] [Related]

  • 17. Sleep quality and nocturnal respiratory function with once-daily theophylline (Uniphyl) and inhaled salbutamol in patients with COPD.
    Man GC, Champman KR, Ali SH, Darke AC.
    Chest; 1996 Sep 13; 110(3):648-53. PubMed ID: 8797406
    [Abstract] [Full Text] [Related]

  • 18. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM, Gunawardena KA, Macmahon MM, Bye A.
    Respir Med; 2000 Feb 13; 94(2):166-73. PubMed ID: 10714424
    [Abstract] [Full Text] [Related]

  • 19. [Salmeterol improves the control of disease in patients with moderate asthma. A comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily].
    Ringbaek TJ, Søes-Petersen U, Christensen M, Iversen ET, Rasmussen FV.
    Ugeskr Laeger; 1996 Jul 01; 158(27):3940-3. PubMed ID: 8701511
    [Abstract] [Full Text] [Related]

  • 20. Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group.
    Waalkens HJ, Van Essen-Zandvliet EE, Hughes MD, Gerritsen J, Duiverman EJ, Knol K, Kerrebijn KF.
    Am Rev Respir Dis; 1993 Nov 01; 148(5):1252-7. PubMed ID: 8239161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.